Selection bias due to immigration in pharmacoepidemiologic studies

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 6, 2007, Pages 681-686

  Støvring, Henrik ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Antidiabetic medications; Pharmacoepidemiology; Prevalence; Selection bias; Waiting time distribution

Indexed keywords

ANTIDIABETIC AGENT;

ARTICLE; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DRUG USE; EPIDEMIOLOGY; FEMALE; HUMAN; IMMIGRATION; MAJOR CLINICAL STUDY; MALE; PHARMACOEPIDEMIOLOGY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS; EMIGRATION AND IMMIGRATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREVALENCE; SELECTION BIAS; TIME FACTORS;

EID: 34447249793     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1419     Document Type: Article

References (15)

1. Meijer WEE, Heerdink E, Leufkens HGM, Herings RMC, Egberts ACG, Nolen WA. Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol 2004; 60: 57-61. DOI: 10.1007/ s00228-004-0726-3
2. Støvring H, Andersen M, Beck-Nielsen H, Green A, Vach W. Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database. The Lancet 2003; 362: 537-538. DOI: 10.1016/ S0140-6736(03)14116-5
3. Rosholm J, Andersen M, Gram L. Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study. Eur J Clin Pharmacol 2001; 56: 923-929.
4. Mantel-Teeuwisse A, Klungel O, Verschuren W, Porsius A, de Boer A. Comparison of different methods to estimate prevalence of drug use by using pharmacy records. J Clin Epidemiol 2001; 54: 1181-1186. DOI: 10.1016/S0895-4356(01)00396-1
5. Thapa P, Gideon P, Cost T, Milam A, Ray W. Antidepressants and the risk of falls among nursing home residents. N Engl J Med 1998; 339: 875-882.
6. Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology 1996; 7: 478-484.
7. Lipworth L, Friis S, Blot WJ, et al. A population-based cohort study of mortality among users of ibuprofen in Denmark. Am J Ther 2004; 11: 156-163.
8. Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia 2004; 45: 1330-1337. DOI: 10.1111/j.0013-9580.2004.18804.x
9. Støvring H. New statistical methods for estimation of prevalence, incidence and mortality based on pharmacoepidemiological and other health-related databases. Ph.D. thesis, Faculty of Health Sciences, University of Southern Denmark, 2002. http.//www.biostat.sdu.dk/~stovring/thesis.pdf
10. Støvring H, Vach W. Estimation of prevalence and incidence based on occurrence of health-related events. Stat Med 2005; 24: 3139-3154. DOI: 10.1002/sim.2142
11. Hallas J, Gaist D, Bjerrum L. The waiting time distribution as a graphical approach to epidemiologic measures of drug utilization. Epidemiology 1997; 8: 666-670.
12. Hallas J, Nissen A. Individualized drug utilization statistics. Analysing a population's drug use from the perspective of individual users. Eur J Clin Pharmacol 1994; 47: 367-372.
13. The WHO Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs and Guidelines for ATC classification and DDD assignment, Oslo, 2001.
14. Rothmann KJ, Greenland S. Modern Epidemiology. Lippincott-Raven Publishers: Philadelphia, 1998.
15. Green A, Hauge M, Holm N, Rasch L Epidemiological studies of diabetes mellitus in Denmark. II. A prevalence study based on insulin prescriptions. Diabetologia 1981; 20: 468-470.